Dr David R Fischler, MD | |
593 Cranbury Rd, Suite 1a, East Brunswick, NJ 08816-4029 | |
(732) 613-8880 | |
(732) 613-0077 |
Full Name | Dr David R Fischler |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 26 Years |
Location | 593 Cranbury Rd, East Brunswick, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275622540 | NPI | - | NPPES |
0103241 | Medicaid | NJ | |
02720212 | Other | NY | NY MEDICAID |
Facility Name | Location | Facility Type |
---|---|---|
Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
Saint Peter's University Hospital | New brunswick, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Robert Wood Johnson Physician Enterprise | 5597917633 | 47 |
Pulmonary And Intensive Care Specialists Of New Jersey | 6204725617 | 7 |
News Archive
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research into the interaction of bacteria with microstructured surfaces in the Department of Physics at the University of Kaiserslautern in Germany.
...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).
During a critical face mask shortage at the start of the COVID-19 pandemic, home sewers responded by pulling out fabric stashes, threading their machines and getting to work.
› Verified 6 days ago
Entity Name | Pulmonary And Intensive Care Specialists Of New Jersey |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366531634 PECOS PAC ID: 6204725617 Enrollment ID: O20040313000106 |
News Archive
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research into the interaction of bacteria with microstructured surfaces in the Department of Physics at the University of Kaiserslautern in Germany.
...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).
During a critical face mask shortage at the start of the COVID-19 pandemic, home sewers responded by pulling out fabric stashes, threading their machines and getting to work.
› Verified 6 days ago
Entity Name | Robert Wood Johnson Physician Enterprise |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245587922 PECOS PAC ID: 5597917633 Enrollment ID: O20121218000345 |
News Archive
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research into the interaction of bacteria with microstructured surfaces in the Department of Physics at the University of Kaiserslautern in Germany.
...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).
During a critical face mask shortage at the start of the COVID-19 pandemic, home sewers responded by pulling out fabric stashes, threading their machines and getting to work.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David R Fischler, MD 593 Cranbury Rd, Suite 1a, East Brunswick, NJ 08816-4029 Ph: (732) 613-8880 | Dr David R Fischler, MD 593 Cranbury Rd, Suite 1a, East Brunswick, NJ 08816-4029 Ph: (732) 613-8880 |
News Archive
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research into the interaction of bacteria with microstructured surfaces in the Department of Physics at the University of Kaiserslautern in Germany.
...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).
During a critical face mask shortage at the start of the COVID-19 pandemic, home sewers responded by pulling out fabric stashes, threading their machines and getting to work.
› Verified 6 days ago
Ellen A Ronnen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 629 Cranbury Rd Fl 2, East Brunswick, NJ 08816 Phone: 732-390-7750 Fax: 732-390-7725 | |
Dr. Alan Sheldon Lichtbroun, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 63 Brunswick Woods Dr, East Brunswick, NJ 08816 Phone: 732-613-1900 Fax: 732-613-0029 | |
Dr. Francis C D'mello, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 385 State Route 18, West Ferris Plaza Unit K, East Brunswick, NJ 08816 Phone: 732-238-4343 Fax: 732-238-6981 | |
Dr. Jose C Costa, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 465 Cranbury Rd, Suite 102, East Brunswick, NJ 08816 Phone: 732-390-1995 Fax: 732-254-4610 | |
Dr. Mervat B Mansour, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2 Auer Ct Ste D, East Brunswick, NJ 08816 Phone: 732-257-5530 Fax: 732-257-5531 | |
Dr. Marsha Kallich, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 579a Cranbury Rd, Suite 102, East Brunswick, NJ 08816 Phone: 732-613-0711 Fax: 732-613-5783 | |
Raafat Ghobraiel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 79 Brunswick Woods Dr, East Brunswick, NJ 08816 Phone: 732-254-7778 |